Home > News > NanoCure Changes Name to Avidimer Therapeutics
May 17th, 2005
NanoCure Changes Name to Avidimer Therapeutics
Abstract:
James R. Baker, Jr., M.D., Avidimer's chairman and chief scientific officer, commented, "The name Avidimer Therapeutics refers to our focus on cell-specific targeting of therapeutics and diagnostics through the use of novel branch-like polymers known as dendrimers, which avidly target diseased cells and have the potential to diagnose and treat cancer and other diseases more effectively and completely than current diagnostics and therapeutics. Their small size (less than 5nm) enables them to escape the blood stream through vascular pores, selectively target and treat tumor cells, and be cleared rapidly through the kidney. Preclinical studies have demonstrated the impressive ability of dendrimers to target diseased cells in the body."
Source:
genengnews.com
Bookmark:
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||